| Literature DB >> 34789756 |
Xiaofu Du1, Le Fang1, Jing Guo2, Xiangyu Chen1, Shuoci Su3, Jie Zhang4.
Abstract
Spot urine (SU) collection is a convenient method commonly used for sodium estimation, but its validity in predicting 24-h urinary sodium (24-hUNa) excretion has not been thoroughly evaluated among the general population. The aim of this study was to comprehensively assess the validity of eight existing methods in predicting 24-hUNa excretion by using SU samples among Chinese adults. We analyzed 1424 representative individuals aged 18 to 69 years. We compared the measured and estimated measurements of 24-hUNa at the population level by examining bias, the correlation, intraclass correlation coefficients (ICCs), receiver operating characteristic (ROC) curves and Bland-Altman plots and analyzed the relative and absolute differences and misclassification at the individual level. The bias for all methods was significant (all p < 0.001), among which the smallest bias was - 7.9 mmol for the Toft formula and the largest bias was - 53.8 mmol for the Mage formula. Correlation coefficients were all less than 0.380, all formulas exhibited an area under the ROC curve below 0.683, and the Bland-Altman plots indicated slightly high dispersion of the estimation biases at higher sodium levels regardless of the formula. The proportions of relative differences > 40% for the eight methods were all over one-third, the proportions of absolute differences > 51.3 mmol/24 h (3 g/day NaCl) were all over 40%, and the misclassification rates (7, 10, and 13 g/day NaCl as cutoff points) were all over 65%. Caution remains due to poor validity between estimated and actual measurements when using the eight formulas to obtain a plausible estimation for surveillance of the Chinese population sodium excretion, and the results do not support the application of SU to estimate sodium intake at the individual level due to its poor performance with respect to classification.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34789756 PMCID: PMC8599737 DOI: 10.1038/s41598-021-00513-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Equations for 24-h urinary sodium excretion based on single spot urine samples.
| Method | Published time | Study population | Age range (years) | Urine specimen | Predictive formula (mmol/24-h) | Applicable population |
|---|---|---|---|---|---|---|
| Kawasaki | 1992 | Japanese Men and women (n = 159) | 20–79 | SMU | Male: 16.3 × [Nasu/(Crsu × 10) × (7.39 × height + 15.12 × weight − 12.63 × age − 79.9)]0.5 Female: 16.3 × [Nasu/(Crsu × 10) × (5.09 × height + 8.58 × weight − 4.72 × age − 74.5)]0.5 | General population |
| Tanaka | 2002 | Japanese Men and women (n = 591) | 20–59 | Casual spot urine | 21.98 × [Nasu/(Crsu × 10) × (16.14 × height + 14.89 × weight-2.04 × age − 2244.45)]0.392 | General population |
| INTERSALT1 | 2012 | Western (North American and European) Men (n = 2841), Women (n = 2852) | 20–59 | Casual spot urine | Male: (0.46 × Nasu + 25.46) − 2.75 × Crsu(mmol/L) − 0.13 × Ksu + 4.10 × BMI + 0.26 × Age Female: (0.34 × Nasu + 5.07) − 2.16 × Crsu(mmol/L) − 0.09 × Ksu + 2.39 × BMI + 2.35 × Age − 0.03 × Age2 | General population |
| INTERSALT2 | 2012 | Western (North American and European) Men (n = 2841), Women (n = 2852) | 20–59 | Casual spot urine | Male: (0.45 × Nasu + 23.51) − 3.09 × Crsu(mmol/L) + 4.16 × BMI + 0.22 × Age Female: (0.33 × Nasu + 3.74) − 2.44 × Crsu(mmol/L) + 2.42 × BMI + 2.34 × Age − 0.03 × Age2 | General population |
| Toft | 2012 | Danish Men and women (n = 473) | 18–65 | Casual spot urine | Male: 33.56 × [Nasu/(Crsu × 10) × (− 7.54 × Age + 14.15 × weight + 3.48 × height + 423.15)]0.345 Female: 52.65 × [Nasu/(Crsu × 10) × (− 6.13 × Age + 9.97 × weight + 2.45 × height + 342.73)]0.196 | General population |
| Whitton | 2016 | Southeast Asian (Singapore residents of Chinese, Malay, and Indian ethnicity) Men and women (n = 144) | 18–79 | SMU | Male: 88.66 + 0.55 × Nasu − 1.34 × Crsu(mmol/L) − 1.05 × Ksu − 0.87 × Age + 2.10 × BMI + 39.30 Female: 88.66 + 0.55 × Nasu − 1.34 × Crsu(mmol/L) − 1.05 × Ksu-0.87 × Age + 2.10 × BMI | General population |
| Mage | 2008 | Used to estimate urine pesticide and chemical exposure with NHANES urine specimens | NA | Casual spot urine | Male: Nasu/(Crsu × 10) × [0.00179 × (140 − Age) × weight1.5 × height0.5] Female: Nasu/(Crsu × 10) × [0.00163 × (140 − Age) × weight1.5 × height0.5] | General population |
| Sun | 2015 | Chinese Men and women with hypertension (n = 334) | 26–76 | SMU | Male: 0.218 × [e(5.961–0.009×Age + 0.005×height + 0.013×weight)] × (Nasu/Crsu/10)0.344 Female: 0.180 × [e(5.824–0.010×Age + 0.007×height + 0.010×weight)] × (Nasu/Crsu/10)0.302 | Hypertension patients, excluding taking antihypertension medicine, secondary hypertension, chronic kidney disease |
The units of concentration for Nasu and Ksu were all mmol/L; unless otherwise specified, the units of Crsu were mg/dl. The units of weight and height were kg and cm.
SMU second morning urine, Na Spot urinary sodium, K Spot urinary potassium, Cr Spot urinary creatinine.
Characteristics of the 1424 participants according to gender.
| All (n = 1424) | Male (n = 697) | Female (n = 727) | ||
|---|---|---|---|---|
| 46.7 ± 14.1 | 46.7 ± 14.4 | 46.7 ± 13.7 | 0.924 | |
| 18–29 (n, %) | 240 (16.9%) | 122 (17.5%) | 118 (16.2%) | |
| 30–39 (n, %) | 266 (18.7%) | 136 (19.5%) | 130 (17.9%) | |
| 40–49 (n, %) | 256 (18.0%) | 120 (17.2%) | 136 (18.7%) | |
| 50–59 (n, %) | 320 (22.5%) | 143 (20.5%) | 177 (24.3%) | |
| 60–69 (n, %) | 342 (24.0%) | 176 (25.3%) | 166 (22.8%) | |
| Weight (kg) | 62.9 ± 10.8 | 67.6 ± 10.4 | 58.4 ± 9.2 | < 0.001 |
| Height (cm) | 161.6 ± 8.1 | 167.1 ± 6.5 | 156.4 ± 5.6 | < 0.001 |
| BMI (kg/m2) | 24.0 ± 3.3 | 24.2 ± 3.2 | 23.9 ± 3.4 | 0.057 |
| Systolic BP (mmHg) | 130.0 ± 19.6 | 133.7 ± 18.2 | 126.5 ± 20.3 | < 0.001 |
| Diastolic BP (mmHg) | 80.0 ± 11.0 | 82.2 ± 10.7 | 77.9 ± 10.8 | < 0.001 |
| Sodium concentration (mmol/L) | 125.1 ± 49.7 | 125.6 ± 48.9 | 124.5 ± 50.5 | 0.675 |
| Potassium concentration (mmol/L) | 32.5 ± 17.0 | 32.6 ± 17.7 | 32.4 ± 16.4 | 0.865 |
| Creatinine concentration (mmol/L) | 12.5 ± 6.5 | 14.2 ± 6.7 | 10.9 ± 5.9 | < 0.001 |
| 24-h urine volume (mL) | 1443.0 ± 441.5 | 1476.8 ± 461.9 | 1410.5 ± 418.8 | 0.005 |
| Sodium excretion (mmol/24-h) | 165.7 ± 71.5 | 172.6 ± 74.5 | 159.1 ± 67.9 | < 0.001 |
| Potassium excretion (mmol/24-h) | 37.2 ± 16.8 | 36.2 ± 18.0 | 38.1 ± 15.4 | 0.030 |
| Creatinine excretion (mmol/24-h) | 9.5 ± 3.9 | 10.9 ± 4.2 | 8.2 ± 3.1 | < 0.001 |
aDifferences between males and females were tested by independent samples t-tests.
Comparison between measured and estimated sodium excretion using eight formulas for 24-hUNa excretion (n = 1424).
| Method | Bias | Estimation accuracyd | Agreement with Bland–Altman plot | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 24-hourUNa (mmol/24-h) | Mean Bias (mmol/24-h, 95% CI)a | rpb | ICC (95% CI)c | AUCe | Sensitivityf | Specificityg | Cutoff value (mmol/24-h)h | 95% of difference (mmol/24-h)i | Probability that estimated value exist within mean ± 1.96 SDj | |
| Measured | 165.7 ± 71.5 | |||||||||
| Kawasaki | 183.8 ± 56.7 | 18.1 (14.3 to 22.0) | 0.345 | 0.32 (0.27 to 0.38) | 0.664 | 49.3% | 75.1% | 187.2 | 291.7 | 94.8% (1350/1424) |
| Tanaka | 142.9 ± 35.6 | − 22.7 (− 26.3 to − 19.1) | 0.327 | 0.24 (0.17 to 0.31) | 0.657 | 55.9% | 67.7% | 140.8 | 269.4 | 94.9% (1352/1424) |
| INTERSALT1 | 133.6 ± 33.7 | − 32.1 (− 35.6 to − 28.5) | 0.340 | 0.23 (0.12 to 0.32) | 0.664 | 65.6% | 60.2% | 124.0 | 266.3 | 94.9% (1351/1424) |
| INTERSALT2 | 130.3 ± 33.5 | − 35.4 (− 38.9 to − 31.9) | 0.342 | 0.22 (0.10 to 0.32) | 0.665 | 63.2% | 62.5% | 122.2 | 266.0 | 95.2% (1356/1424) |
| Toft | 157.8 ± 39.1 | − 7.9 (− 11.5 to − 4.2) | 0.303 | 0.25 (0.20 to 0.30) | 0.633 | 65.4% | 55.6% | 141.0 | 275.8 | 95.2% (1355/1424) |
| Whitton | 135.6 ± 38.2 | − 30.1 (− 33.6 to − 26.6) | 0.370 | 0.27 (0.16 to 0.36) | 0.676 | 55.1% | 73.9% | 140.8 | 264.7 | 95.6% (1362/1424) |
| Mage | 111.9 ± 77.4 | − 53.8 (− 58.3 to − 49.4) | 0.343 | 0.27 (0.09 to 0.41) | 0.679 | 57.1% | 69.1% | 93.4 | 335.2 | 94.9% (1351/1424) |
| Sun | 121.2 ± 35.7 | − 44.5 (− 48.0 to − 41.0) | 0.380 | 0.23 (0.06 to 0.37) | 0.683 | 61.3% | 68.3% | 114.6 | 261.7 | 94.8% (1350/1424) |
24-hUNa 24-h urinary sodium, r Pearson correlation coefficient, ICC intraclass correlation coefficients, AUC area under the curve.
aMean bias all p < 0.001.
bPerson correlation all p < 0.001.
cThe values of single measures were used, and all p < 0.001.
dThe results of accuracy of prediction come from ROC curve.
eArea under the ROC curve for predicting 24-hUNa in individuals whose sodium intake was ≥ 3000 mg/24-h (AUC), and the p value represents the significance value to refute the null hypothesis of being nondiscriminatory, and all p < 0.001.
fThe sensitivity is defined as the proportion of individuals whose measured 24-h urinary sodium ≥ 3000 mg with the estimated amount ≥ 3000 mg at the cutoff value.
gThe specificity is defined as the proportion of individuals whose measured 24-h urinary sodium < 3000 mg with the estimated amount < 3000 mg at the cutoff value.
hThe cutoff value is defined as the corresponding detection value at the maximum value of [sensitivity − (1 − specificity)].
iNinety-five percent of the difference is the width between the upper limit and lower limit in the Bland–Altman plot.
jThe probability that the difference between the measured and estimated values existed within − 1.96 SD and + 1.96 SD of the mean value in the Bland–Altman plot.
Figure 1Area under the ROC curve for predicting the 24-h urinary sodium level among individuals whose sodium level was more than 3000 mg/24 h.
Figure 2Bland–Altman plots of the estimated and measured 24-h urinary sodium excretion based on the Kawasaki Equation (A), Tanaka Equation (B), INTERSALT1 Equation (C), INTERSALT2 Equation (D), Toft Equation (E), Whitton Equation (F), Mage Equation (G), and Sun Equation (H).
Figure 3Relative and absolute difference distributions of 24-h urinary sodium excretion estimated based on eight equations. Relative difference (A) and absolute difference (B).
Misclassification of the eight predicted methods for individual salt intake level, n (%).
| Method | Conversion of salt intake by 24-hUNa excretion | Total (n = 1424) | |||
|---|---|---|---|---|---|
| < 7 g/24-h (n = 396) | 7–9.99 g/24-h (n = 434) | 10–12.99 g/24-h (n = 320) | ≥ 13 g/24-h (n = 274) | ||
| < 7 g/24-h | 43 (10.0) | 17 (5.3) | 5 (1.8) | – | |
| 7–9.99 g/24-h | 168 (42.4) | 102 (32.0) | 67 (24.5) | – | |
| 10–12.99 g/24-h | 112 (28.3) | 120 (27.8) | 86 (31.5) | – | |
| ≥ 13 g/24-h | 43 (10.9) | 78 (18.1) | 88 (27.6) | – | |
| Misclassification | 323 (81.6) | 244 (56.2) | 208 (65.0) | 159 (58.0) | 934 (65.6) |
| < 7 g/24-h | 133 (30.9) | 57 (17.9) | 38 (13.9) | – | |
| 7–9.99 g/24-h | 195 (49.2) | 183 (57.4) | 138 (50.5) | – | |
| 10–12.99 g/24-h | 39 (9.8) | 63 (14.6) | 81 (29.7) | – | |
| ≥ 13 g/24-h | 4 (1.0) | 10 (2.3) | 7 (2.2) | – | |
| Misclassification | 238 (60.1) | 209 (48.2) | 248 (77.5) | 258 (94.2) | 953 (66.9) |
| < 7 g/24-h | 197 (45.7) | 86 (27.0) | 48 (17.6) | – | |
| 7–9.99 g/24-h | 170 (42.9) | 171 (53.6) | 148 (54.2) | – | |
| 10–12.99 g/24-h | 23 (5.8) | 50 (11.6) | 72 (26.4) | – | |
| ≥ 13 g/24-h | 0 (0.0) | 0 (0.0) | 1 (0.3) | – | |
| Misclassification | 193 (48.7) | 250 (57.6) | 259 (80.9) | 269 (98.2) | 971 (68.2) |
| < 7 g/24-h | 214 (49.7) | 99 (31.0) | 58 (21.2) | – | |
| 7–9.99 g/24-h | 151 (38.1) | 166 (52.0) | 145 (53.1) | – | |
| 10–12.99 g/24-h | 21 (5.3) | 43 (10.0) | 67 (24.5) | – | |
| ≥ 13 g/24-h | 0 (0.0) | 0 (0.0) | 1 (0.3) | – | |
| Misclassification | 172 (43.4) | 260 (59.9) | 267 (83.4) | 271 (98.9) | 970 (68.1) |
| < 7 g/24-h | 61 (14.2) | 21 (6.6) | 7 (2.6) | – | |
| 7–9.99 g/24-h | 243 (61.4) | 185 (58.0) | 140 (51.3) | – | |
| 10–12.99 g/24-h | 63 (15.9) | 80 (18.6) | 79 (28.9) | – | |
| ≥ 13 g/24-h | 14 (3.5) | 26 (6.0) | 23 (7.2) | – | |
| Misclassification | 320 (80.8) | 170 (39.2) | 230 (71.9) | 227 (82.8) | 947 (66.5) |
| < 7 g/24-h | 175 (40.6) | 80 (25.1) | 41 (15.0) | – | |
| 7–9.99 g/24-h | 176 (44.4) | 183 (57.4) | 132 (48.4) | – | |
| 10–12.99 g/24-h | 30 (7.6) | 54 (12.5) | 94 (34.4) | – | |
| ≥ 13 g/24-h | 1 (0.3) | 3 (0.7) | 4 (1.3) | – | |
| Misclassification | 207 (52.3) | 235 (54.1) | 268 (83.8) | 268 (97.8) | 978 (68.7) |
| < 7 g/24-h | 319 (74.0) | 182 (57.1) | 112 (41.0) | – | |
| 7–9.99 g/24-h | 47 (11.9) | 76 (23.8) | 72 (26.4) | – | |
| 10–12.99 g/24-h | 14 (3.5) | 39 (9.0) | 36 (13.2) | – | |
| ≥ 13 g/24-h | 12 (3.0) | 25 (5.8) | 29 (9.1) | – | |
| Misclassification | 73 (18.4) | 386 (88.9) | 288 (90.0) | 221 (80.7) | 968 (68.0) |
| < 7 g/24-h | 269 (62.4) | 154 (48.3) | 78 (28.6) | – | |
| 7–9.99 g/24-h | 97 (24.5) | 140 (43.9) | 137 (50.2) | – | |
| 10–12.99 g/24-h | 12 (3.0) | 21 (4.9) | 44 (16.1) | – | |
| ≥ 13 g/24-h | 3 (0.8) | 3 (0.7) | 2 (0.6) | – | |
| Misclassification | 112 (28.3) | 296 (68.2) | 297 (92.8) | 260 (94.9) | 965 (67.8) |
The numbers in bold in the table indicate the number and percentage of cases where the estimated value is consistent with the measured 24-hUNa excretion value